Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET.

Kahnert K, Föhrenbach M, Lucke T, Alter P, Trudzinski FT, Bals R, Lutter JI, Timmermann H, Söhler S, Förderreuther S, Nowak D, Watz H, Waschki B, Behr J, Welte T, Vogelmeier CF, Jörres RA.

Respir Res. 2020 Jan 20;21(1):28. doi: 10.1186/s12931-020-1293-6.

2.

High-sensitivity troponin I and all-cause mortality in patients with stable COPD: An analysis of the COSYCONET study.

Waschki B, Alter P, Zeller T, Magnussen C, Neumann JT, Twerenbold R, Sinning C, Herr C, Kahnert K, Fähndrich S, Blankenberg S, Rabe KF, Welte T, Jörres RA, Vogelmeier CF, Bals R, Watz H; German COSYCONET Cohort.

Eur Respir J. 2019 Dec 12. pii: 1901314. doi: 10.1183/13993003.01314-2019. [Epub ahead of print]

PMID:
31831579
3.

Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology.

Veith M, Klemmer A, Anton I, El Hamss R, Rapun N, Janciauskiene S, Kotke V, Herr C, Bals R, Vogelmeier CF, Greulich T.

Int J Chron Obstruct Pulmon Dis. 2019 Nov 18;14:2535-2542. doi: 10.2147/COPD.S224221. eCollection 2019.

4.

Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation.

Zewinger S, Reiser J, Jankowski V, Alansary D, Hahm E, Triem S, Klug M, Schunk SJ, Schmit D, Kramann R, Körbel C, Ampofo E, Laschke MW, Selejan SR, Paschen A, Herter T, Schuster S, Silbernagel G, Sester M, Sester U, Aßmann G, Bals R, Kostner G, Jahnen-Dechent W, Menger MD, Rohrer L, März W, Böhm M, Jankowski J, Kopf M, Latz E, Niemeyer BA, Fliser D, Laufs U, Speer T.

Nat Immunol. 2020 Jan;21(1):30-41. doi: 10.1038/s41590-019-0548-1. Epub 2019 Dec 9.

PMID:
31819254
5.

CAT score single item analysis in patients with COPD: Results from COSYCONET.

Marietta von Siemens S, Alter P, Lutter JI, Kauczor HU, Jobst B, Bals R, Trudzinski FC, Söhler S, Behr J, Watz H, Waschki B, Bewig B, Jones PW, Welte T, Vogelmeier CF, Jörres RA, Kahnert K; COSYCONET study group; Names of participating study nurses.

Respir Med. 2019 Nov;159:105810. doi: 10.1016/j.rmed.2019.105810. Epub 2019 Nov 7.

PMID:
31739262
6.

Time-updated resting heart rate predicts mortality in patients with COPD.

Omlor AJ, Trudzinski FC, Alqudrah M, Seiler F, Biertz F, Vogelmeier CF, Welte T, Watz H, Waschki B, Brinker TJ, Andreas S, Fähndrich S, Alter P, Jörres RA, Böhm M, Bals R; German COSYCONET Cohort.

Clin Res Cardiol. 2019 Nov 16. doi: 10.1007/s00392-019-01572-1. [Epub ahead of print]

PMID:
31734762
7.

The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort.

von Siemens SM, Perneczky R, Vogelmeier CF, Behr J, Kauffmann-Guerrero D, Alter P, Trudzinski FC, Bals R, Grohé C, Söhler S, Waschki B, Lutter JI, Welte T, Jörres RA, Kahnert K; COSYCONET study group.

Respir Res. 2019 Nov 14;20(1):257. doi: 10.1186/s12931-019-1217-5.

8.

The Phagocytosis of Blood Leukocytes from Cystic Fibrosis Patients is not Impaired in General.

Leuer L, Krill A, Wilkens H, Wagenpfeil G, Bischoff M, Meier C, Bals R, Tschernig T.

Lung. 2019 Nov 9. doi: 10.1007/s00408-019-00290-9. [Epub ahead of print]

PMID:
31707460
9.

Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort.

Königsdorfer N, Jörres RA, Söhler S, Welte T, Behr J, Ficker JH, Bals R, Watz H, Lutter JI, Lucke T, Biertz F, Alter P, Vogelmeier CF, Kahnert K.

Patient Prefer Adherence. 2019 Oct 10;13:1711-1721. doi: 10.2147/PPA.S223438. eCollection 2019.

10.

Association of NLRP1 Coding Polymorphism with Lung Function and Serum IL-1β Concentration in Patients Diagnosed with Chronic Obstructive Pulmonary Disease (COPD).

Ozretić P, da Silva Filho MI, Catalano C, Sokolović I, Vukić-Dugac A, Šutić M, Kurtović M, Bubanović G, Popović-Grle S, Skrinjarić-Cincar S, Vugrek O, Jukić I, Rumora L, Bosnar M, Samaržija M, Bals R, Jakopović M, Försti A, Knežević J.

Genes (Basel). 2019 Oct 9;10(10). pii: E783. doi: 10.3390/genes10100783.

11.

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort.

Alter P, Mayerhofer BA, Kahnert K, Watz H, Waschki B, Andreas S, Biertz F, Bals R, Vogelmeier CF, Jörres RA.

Int J Chron Obstruct Pulmon Dis. 2019 Sep 20;14:2163-2172. doi: 10.2147/COPD.S209343. eCollection 2019.

12.

Low miR-150-5p and miR-320b Expression Predicts Reduced Survival of COPD Patients.

Keller A, Ludwig N, Fehlmann T, Kahraman M, Backes C, Kern F, Vogelmeier CF, Diener C, Fischer U, Biertz F, Herr C, Jörres RA, Lenhof HP, Bals R, Meese E.

Cells. 2019 Sep 27;8(10). pii: E1162. doi: 10.3390/cells8101162.

13.

[Expert Workshop COPD: Lungs and Heart - Quite Often Ill Together].

Jany B, Bals R, Dreher M, Held M, Jany L, Rembert Koczulla A, Pfeifer M, Randerath W, Watz H, Wilkens H, Steinkamp G.

Pneumologie. 2019 Nov;73(11):651-669. doi: 10.1055/a-0914-9566. Epub 2019 Sep 9. German.

PMID:
31499562
14.

Interleukin 17 Receptor E (IL-17RE) and IL-17C Mediate the Recruitment of Neutrophils during Acute Streptococcus pneumoniae Pneumonia.

Steck P, Ritzmann F, Honecker A, Vella G, Herr C, Gaupp R, Bischoff M, Speer T, Tschernig T, Bals R, Beisswenger C.

Infect Immun. 2019 Oct 18;87(11). pii: e00329-19. doi: 10.1128/IAI.00329-19. Print 2019 Nov.

PMID:
31481409
15.

[Experience of disease, relationship and sexuality in patients with COPD].

Borgmann M, Linnemann T, Schönhofer B, Ott SR, Bernardy K, Stammberger U, Vedder V, Bals R, Köllner V, Hamacher J.

Z Psychosom Med Psychother. 2019 Sep;65(3):257-271. doi: 10.13109/zptm.2019.65.3.257. German.

PMID:
31476995
16.

Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD.

Stolk J, Tov N, Chapman KR, Fernandez P, MacNee W, Hopkinson NS, Piitulainen E, Seersholm N, Vogelmeier CF, Bals R, McElvaney G, Stockley RA.

Eur Respir J. 2019 Nov 21;54(5). pii: 1900673. doi: 10.1183/13993003.00673-2019. Print 2019 Nov.

PMID:
31467115
17.

IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer.

Ritzmann F, Jungnickel C, Vella G, Kamyschnikow A, Herr C, Li D, Menger MM, Angenendt A, Hoth M, Lis A, Bals R, Beisswenger C.

Sci Rep. 2019 Jul 17;9(1):10353. doi: 10.1038/s41598-019-46759-8.

18.

Consequences of chronic kidney disease in chronic obstructive pulmonary disease.

Trudzinski FC, Alqudrah M, Omlor A, Zewinger S, Fliser D, Speer T, Seiler F, Biertz F, Koch A, Vogelmeier C, Welte T, Watz H, Waschki B, Fähndrich S, Jörres R, Bals R; German COSYCONET consortium.

Respir Res. 2019 Jul 12;20(1):151. doi: 10.1186/s12931-019-1107-x.

19.

Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort.

Trudzinski FC, Kahnert K, Vogelmeier CF, Alter P, Seiler F, Fähndrich S, Watz H, Welte T, Speer T, Zewinger S, Biertz F, Kauczor HU, Jörres RA, Bals R; COSYCONET consortium.

Respir Med. 2019 Jul - Aug;154:18-26. doi: 10.1016/j.rmed.2019.06.007. Epub 2019 Jun 11.

PMID:
31203096
20.

Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling.

Ji P, Zhou Y, Yang Y, Wu J, Zhou H, Quan W, Sun J, Yao Y, Shang A, Gu C, Zeng B, Firrman J, Xiao W, Bals R, Sun Z, Li D.

Theranostics. 2019 Apr 12;9(8):2209-2223. doi: 10.7150/thno.30726. eCollection 2019.

21.

Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.

Hamesch K, Mandorfer M, Pereira VM, Moeller LS, Pons M, Dolman GE, Reichert MC, Schneider CV, Woditsch V, Voss J, Lindhauer C, Fromme M, Spivak I, Guldiken N, Zhou B, Arslanow A, Schaefer B, Zoller H, Aigner E, Reiberger T, Wetzel M, Siegmund B, Simões C, Gaspar R, Maia L, Costa D, Bento-Miranda M, van Helden J, Yagmur E, Bzdok D, Stolk J, Gleiber W, Knipel V, Windisch W, Mahadeva R, Bals R, Koczulla R, Barrecheguren M, Miravitlles M, Janciauskiene S, Stickel F, Lammert F, Liberal R, Genesca J, Griffiths WJ, Trauner M, Krag A, Trautwein C, Strnad P; European Alpha1-Liver Study Group.

Gastroenterology. 2019 Sep;157(3):705-719.e18. doi: 10.1053/j.gastro.2019.05.013. Epub 2019 May 20.

PMID:
31121167
22.

[Epidemiology, Clinical Presentation, Diagnosis and Treatment of Infections Caused by Mycobacterium chimaera].

Becker SL, Schlotthauer U, Schäfers HJ, Bals R, Trudzinski FC.

Pneumologie. 2019 Aug;73(8):474-481. doi: 10.1055/a-0872-8809. Epub 2019 May 10. Review. German.

PMID:
31075795
23.

Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD.

Alter P, Watz H, Kahnert K, Rabe KF, Biertz F, Fischer R, Jung P, Graf J, Bals R, Vogelmeier CF, Jörres RA.

Respir Res. 2019 Mar 27;20(1):61. doi: 10.1186/s12931-019-1025-y.

24.

A murine model to study vasoreactivity and intravascular flow in lung isograft microvessels.

Regelin N, Heyder S, Laschke MW, Hadizamani Y, Borgmann M, Moehrlen U, Schramm R, Bals R, Menger MD, Hamacher J.

Sci Rep. 2019 Mar 26;9(1):5170. doi: 10.1038/s41598-019-41590-7.

25.

Profiling of Alzheimer's disease related genes in mild to moderate vitamin D hypovitaminosis.

Grimm MOW, Lauer AA, Grösgen S, Thiel A, Lehmann J, Winkler J, Janitschke D, Herr C, Beisswenger C, Bals R, Grimm HS, Hartmann T.

J Nutr Biochem. 2019 May;67:123-137. doi: 10.1016/j.jnutbio.2019.01.015. Epub 2019 Feb 11.

PMID:
30889441
26.

COPD: Rethinking Patient Management - How to Approach a Challenging Patient Group Successfully.

Jany BH, Bals R, Buhr-Schinner H, Dreher M, Koczulla AR, Jany L, Meyer A, Randerath W.

Respiration. 2019;97(4):363-368. doi: 10.1159/000493759. Epub 2019 Mar 15. Review.

PMID:
30879009
27.

The composition of the pulmonary microbiota in sarcoidosis - an observational study.

Becker A, Vella G, Galata V, Rentz K, Beisswenger C, Herr C, Walter J, Tierling S, Slevogt H, Keller A, Bals R.

Respir Res. 2019 Feb 28;20(1):46. doi: 10.1186/s12931-019-1013-2.

28.

Acute Moraxella catarrhalis Airway Infection of Chronically Smoke-Exposed Mice Increases Mechanisms of Emphysema Development: A Pilot Study.

Fischer K, Doehn JM, Herr C, Lachner C, Heinrich A, Kershaw O, Voss M, Jacobson MH, Gruber AD, Clauss M, Witzenrath M, Bals R, Gutbier B, Slevogt H.

Eur J Microbiol Immunol (Bp). 2018 Dec 11;8(4):128-134. doi: 10.1556/1886.2018.00019. eCollection 2018 Dec 23.

29.

Large-scale validation of miRNAs by disease association, evolutionary conservation and pathway activity.

Fehlmann T, Laufer T, Backes C, Kahramann M, Alles J, Fischer U, Minet M, Ludwig N, Kern F, Kehl T, Galata V, Düsterloh A, Schrörs H, Kohlhaas J, Bals R, Huwer H, Geffers L, Krüger R, Balling R, Lenhof HP, Meese E, Keller A.

RNA Biol. 2019 Jan;16(1):93-103. doi: 10.1080/15476286.2018.1559689. Epub 2018 Dec 26.

30.

Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.

Hechtner M, Eichler M, Wehler B, Buhl R, Sebastian M, Stratmann J, Schmidberger H, Gohrbandt B, Peuser J, Kortsik C, Nestle U, Wiesemann S, Wirtz H, Wehler T, Bals R, Blettner M, Singer S.

J Thorac Oncol. 2019 Mar;14(3):420-435. doi: 10.1016/j.jtho.2018.11.019. Epub 2018 Nov 30.

PMID:
30508641
31.

Electronic cigarettes: a task force report from the European Respiratory Society.

Bals R, Boyd J, Esposito S, Foronjy R, Hiemstra PS, Jiménez-Ruiz CA, Katsaounou P, Lindberg A, Metz C, Schober W, Spira A, Blasi F.

Eur Respir J. 2019 Jan 31;53(2). pii: 1801151. doi: 10.1183/13993003.01151-2018. Print 2019 Feb.

PMID:
30464018
32.

[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].

Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupoldt A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.

Pneumologie. 2017 Dec;71(12):e3. doi: 10.1055/a-0790-0021. Epub 2018 Nov 7. German. No abstract available.

PMID:
30406626
33.

Alternative Oxidase Attenuates Cigarette Smoke-induced Lung Dysfunction and Tissue Damage.

Giordano L, Farnham A, Dhandapani PK, Salminen L, Bhaskaran J, Voswinckel R, Rauschkolb P, Scheibe S, Sommer N, Beisswenger C, Weissmann N, Braun T, Jacobs HT, Bals R, Herr C, Szibor M.

Am J Respir Cell Mol Biol. 2019 May;60(5):515-522. doi: 10.1165/rcmb.2018-0261OC.

34.

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort.

Greulich T, Mager S, Lucke T, Koczulla AR, Bals R, Fähndrich S, Jörres RA, Alter P, Kirsten A, Vogelmeier CF, Watz H.

Int J Chron Obstruct Pulmon Dis. 2018 Sep 28;13:2999-3002. doi: 10.2147/COPD.S165909. eCollection 2018. No abstract available.

35.

Improving Outcomes in Bridge-to-Transplant: Extended Extracorporeal Membrane Oxygenation Support to Obtain Optimal Donor Lungs for Marginal Recipients.

Langer F, Aliyev P, Schäfers HJ, Trudzinski FC, Seiler F, Bals R, Wilkens H, Lepper PM.

ASAIO J. 2019 Jul;65(5):516-521. doi: 10.1097/MAT.0000000000000843.

PMID:
30044239
36.

Genome-wide MicroRNA Expression Profiles in COPD: Early Predictors for Cancer Development.

Keller A, Fehlmann T, Ludwig N, Kahraman M, Laufer T, Backes C, Vogelmeier C, Diener C, Biertz F, Herr C, Jörres RA, Lenhof HP, Meese E, Bals R; COSYCONET Study Group.

Genomics Proteomics Bioinformatics. 2018 Jun;16(3):162-171. doi: 10.1016/j.gpb.2018.06.001. Epub 2018 Jul 5.

37.

[Expert Meeting: Integrated Care of the COPD Patients].

Jany B, Bals R, Buhr-Schinner H, Dreher M, Koczulla R, Jany L, Meyer A, Randerath W, Steinkamp G.

Pneumologie. 2018 Sep;72(9):624-640. doi: 10.1055/a-0620-1002. Epub 2018 Jun 28. German.

PMID:
29954020
38.

Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach.

Kahnert K, Alter P, Welte T, Huber RM, Behr J, Biertz F, Watz H, Bals R, Vogelmeier CF, Jörres RA.

Respir Res. 2018 Jun 4;19(1):110. doi: 10.1186/s12931-018-0815-y.

39.

Murine alveolar epithelial cells and their lentivirus-mediated immortalisation.

Sapich S, Hittinger M, Hendrix-Jastrzebski R, Repnik U, Griffiths G, May T, Wirth D, Bals R, Schneider-Daum N, Lehr CM.

Altern Lab Anim. 2018 May;46(2):73-89.

PMID:
29856645
40.

Weaning from prolonged veno-venous extracorporeal membrane oxygenation (ECMO) after transfer to a specialized center: a retrospective study.

Seiler F, Trudzinski FC, Hörsch SI, Kamp A, Metz C, Flaig M, Alqudrah M, Wehrfritz H, Kredel M, Muellenbach RM, Haake H, Bals R, Lepper PM.

J Artif Organs. 2018 Sep;21(3):300-307. doi: 10.1007/s10047-018-1046-1. Epub 2018 May 15.

PMID:
29766320
41.

Cerebral oxygen availability during exercise in COPD patients with cognitive impairment.

Andrianopoulos V, Vogiatzis I, Gloeckl R, Bals R, Koczulla RA, Kenn K.

Respir Physiol Neurobiol. 2018 Aug;254:64-72. doi: 10.1016/j.resp.2018.05.001. Epub 2018 May 2.

PMID:
29729396
42.

Decreased Migration of Dendritic Cells into the Jugular-Nodose Ganglia by the CXCL12 Neutraligand Chalcone 4 in Ovalbumin-Sensitized Asthmatic Mice.

Heck S, Daubeuf F, Le DD, Sester M, Bonnet D, Bals R, Frossard N, Dinh QT.

Neuroimmunomodulation. 2017;24(6):331-340. doi: 10.1159/000487140. Epub 2018 Apr 20.

PMID:
29680839
43.

Left ventricular volume and wall stress are linked to lung function impairment in COPD.

Alter P, Jörres RA, Watz H, Welte T, Gläser S, Schulz H, Bals R, Karch A, Wouters EFM, Vestbo J, Young D, Vogelmeier CF.

Int J Cardiol. 2018 Jun 15;261:172-178. doi: 10.1016/j.ijcard.2018.02.074.

PMID:
29657040
44.

Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling.

Alter P, Watz H, Kahnert K, Pfeifer M, Randerath WJ, Andreas S, Waschki B, Kleibrink BE, Welte T, Bals R, Schulz H, Biertz F, Young D, Vogelmeier CF, Jörres RA.

Respir Med. 2018 Apr;137:14-22. doi: 10.1016/j.rmed.2018.02.011. Epub 2018 Feb 19.

PMID:
29605197
45.

Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.

Turner AM, Stolk J, Bals R, Lickliter JD, Hamilton J, Christianson DR, Given BD, Burdon JG, Loomba R, Stoller JK, Teckman JH.

J Hepatol. 2018 Aug;69(2):378-384. doi: 10.1016/j.jhep.2018.03.012. Epub 2018 Mar 21.

PMID:
29572094
46.

Effects of E-Cigarette Use on Human Lung Tissue. On Harm Reduction and Causing Harm.

Hiemstra PS, Bals R.

Am J Respir Crit Care Med. 2018 Jul 1;198(1):6-7. doi: 10.1164/rccm.201802-0299ED. No abstract available.

PMID:
29518342
47.

Percutaneous Mechanical Circulation Support Combined with Extracorporeal Membrane Oxygenation (oxyRVAD) in Secondary Right Heart Failure.

Lepper PM, Hörsch SI, Seiler F, Kamp A, Becker SL, Lensch C, Conzelmann LO, Haake H, Muellenbach RM, Bals R, Kredel M, Langer F, Wilkens H, Trudzinski FC.

ASAIO J. 2018 Jul/Aug;64(4):e64-e67. doi: 10.1097/MAT.0000000000000754.

PMID:
29419538
48.

The revised GOLD 2017 COPD categorization in relation to comorbidities.

Kahnert K, Alter P, Young D, Lucke T, Heinrich J, Huber RM, Behr J, Wacker M, Biertz F, Watz H, Bals R, Welte T, Wirtz H, Herth F, Vestbo J, Wouters EF, Vogelmeier CF, Jörres RA.

Respir Med. 2018 Jan;134:79-85. doi: 10.1016/j.rmed.2017.12.003. Epub 2017 Dec 5.

49.

[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].

Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupold A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.

Pneumologie. 2017 Dec;71(12):e2. doi: 10.1055/s-0044-100881. Epub 2018 Jan 15. German. No abstract available.

PMID:
29334688
50.

Microbiological airway colonization in COPD patients with severe emphysema undergoing endoscopic lung volume reduction.

Trudzinski FC, Seiler F, Wilkens H, Metz C, Kamp A, Bals R, Gärtner B, Lepper PM, Becker SL.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 19;13:29-35. doi: 10.2147/COPD.S150705. eCollection 2018.

Supplemental Content

Support Center